Amarantus Bioscience Holdings Inc (AMBS)

[SpecTrader]

LymPro is poised to undergo validation testing

required for its use as a laboratory-developed test by CLIA-certified laboratories. The ultimate aim is to progress the assay through FDA approval. Development of the test to date has been supported by NIH research grants. ~AMBS

http://www.genengnews.com/keywordsandtools/print/4/29113/